Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield - Trial NCT06214936
Access comprehensive clinical trial information for NCT06214936 through Pure Global AI's free database. This phase not specified trial is sponsored by Reproductive Medicine Associates of New Jersey and is currently Recruiting. The study focuses on Infertility. Target enrollment is 252 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Reproductive Medicine Associates of New Jersey
Timeline & Enrollment
N/A
Dec 19, 2023
Jun 01, 2026
Primary Outcome
Blastulation Rate per mature oocyte (M2)
Summary
The goal of this study is to determine if benchtop incubators improve the number of embryos
 making it to the blastocyst stage of development (about 4-6 days after fertilization) in
 people undergoing in vitro fertilization (IVF) treatment for their infertility.
 
 - Test the effectiveness of the benchtop incubator.
 
 - Determine if the number of embryos reaching the blastocyst stage of embryo development
 (the stage that the embryos are biopsied for PGT-A and frozen) is improved in the
 benchtop incubator compared to the box incubator.
 
 - Compare embryology outcomes between the two incubator types.
 
 - Investigate transfer and pregnancy outcomes.
 
 - Expand the knowledge surrounding the impact of the incubator on IVF outcomes. Patients
 will have their mature oocytes collected at the egg retrieval procedure split into two
 groups and randomized to be cultured in both incubator types.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06214936
Non-Device Trial